Literature DB >> 15326520

Synthesis and biological evaluation of new inhibitors of UDP-Galf transferase--a key enzyme in M. tuberculosis cell wall biosynthesis.

Sylvaine Cren1, Sudagar S Gurcha, Alexander J Blake, Gurdyal S Besra, Neil R Thomas.   

Abstract

Two iminosugars have been designed and synthesized as potential inhibitors of UDP-Galf transferase, an enzyme involved in Mycobacterium tuberculosis cell wall biosynthesis. The design is based on a proposed model of the transition state for the transferase reaction. One of the two racemic compounds is the first reported inhibitor of the target enzyme from M. smegmatis. Copyright 2004 The Royal Society of Chemistry

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326520     DOI: 10.1039/B411554F

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

1.  Synthetic UDP-furanoses as potent inhibitors of mycobacterial galactan biogenesis.

Authors:  Pauline Peltier; Martina Beláňová; Petronela Dianišková; Ruokun Zhou; Ruixiang Blake Zheng; Jean A Pearcey; Maju Joe; Patrick J Brennan; Caroline Nugier-Chauvin; Vincent Ferrières; Todd L Lowary; Richard Daniellou; Katarína Mikušová
Journal:  Chem Biol       Date:  2010-12-22

2.  Design and synthesis of potent "sulfur-free" transition state analogue inhibitors of 5'-methylthioadenosine nucleosidase and 5'-methylthioadenosine phosphorylase.

Authors:  Alistair I Longshaw; Florian Adanitsch; Jemy A Gutierrez; Gary B Evans; Peter C Tyler; Vern L Schramm
Journal:  J Med Chem       Date:  2010-09-23       Impact factor: 7.446

3.  Evaluation of the Mycobactericidal Effect of Thio-functionalized Carbohydrate Derivatives.

Authors:  Małgorzata Korycka-Machała; Anna Brzostek; Bożena Dziadek; Malwina Kawka; Tomasz Popławski; Zbigniew J Witczak; Jarosław Dziadek
Journal:  Molecules       Date:  2017-05-16       Impact factor: 4.411

Review 4.  Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target?

Authors:  Zuzana Konyariková; Karin Savková; Stanislav Kozmon; Katarína Mikušová
Journal:  Antibiotics (Basel)       Date:  2020-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.